Sanacija Odrona U Čestobrodici

Lukić, Miketa; Marinković, Zoran

doi:10.14415/konferencijagfs2016.064

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1218 Second, there must be a real, objective fear for the safety of the witness. The evaluation of risk and danger has to be done on a witness-bywitness basis, 1219 and also the party seeking protective measures carries the burden of proof of establishing 'exceptional circumstances'. 1220 Generally speaking, do not constitute 'exceptional circumstances': i) general allegations of dangerous conditions or threats to the welfare of victims and witnesses; and ii) the fear that the Prosecutor may have difficulties in finding witnesses who are willing to testify in future cases.…”

Section: Situation At the Icty The Ictr And The Scsl 321 Protection B...mentioning

confidence: 99%

Victims’ Status at International and Hybrid Criminal Courts: Victims’ Status as Witnesses, Victim Participants/Civil Parties and Reparations Claimants

Perez-Leon-Acevedo¹

2018

Finnish Yearbook of International Law

View full text Add to dashboard Cite

show abstract

Section: Situation At the Icty The Ictr And The Scsl 321 Protection B...mentioning

confidence: 99%

Victims’ Status at International and Hybrid Criminal Courts: Victims’ Status as Witnesses, Victim Participants/Civil Parties and Reparations Claimants

Perez-Leon-Acevedo¹

2018

Finnish Yearbook of International Law

View full text Add to dashboard Cite

show abstract

Effect of Dyslipidemia Therapy on Creatinine Kinase Activity Level in Patients with Heart Disease

Sulistian¹,

Fuadi²,

Edijanto³

et al. 2021

Indonesian J. Clin. Pathol. Med. Lab.

View full text Add to dashboard Cite

Cardiovascular disease remains a significant health problem in the Asia Pacific region. Several studies have found that dyslipidemia is a cause of morbidity and mortality and requires high medical costs. Dyslipidemia is a risk factor for atherosclerosis. The most widely used therapy for dyslipidemia is statins. Statins often cause muscle disorders such as myalgia, myopathy, and rhabdomyolysis, which can cause death. A prospective cohort study design was carried out at Airlangga University Hospital, Surabaya, from April to November 2019. A total of 26 sample pairs containing 13 samples were treated with Atorvastatin, and 13 samples were treated with Simvastatin. The subjects were examined for the creatinine kinase activity level using enzymatic methods. The mean creatinine kinase levels in the atorvastatin group before and after treatment was 105.71 IU/L and 100.03 IU/L, respectively, because the subjects were diagnosed with acute coronary syndromes and blood was collected during acute conditions. Median creatinine kinase levels in the Simvastatin group were 85.5 IU/L before therapy and 118.1 IU/L after therapy, indicating significant differences in creatinine kinase levels before and after treatment. Simvastatin is very susceptible to certain drug interactions that can increase the concentration of statins in the serum. There were differences in levels of creatinine kinase activity before and after Simvastatin therapy but not Atorvastatin.

show abstract

Sanacija Odrona U Čestobrodici

Cited by 2 publications

References 0 publications

Victims’ Status at International and Hybrid Criminal Courts: Victims’ Status as Witnesses, Victim Participants/Civil Parties and Reparations Claimants

Victims’ Status at International and Hybrid Criminal Courts: Victims’ Status as Witnesses, Victim Participants/Civil Parties and Reparations Claimants

Effect of Dyslipidemia Therapy on Creatinine Kinase Activity Level in Patients with Heart Disease

Contact Info

Product

Resources

About